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Background: Campylobacter jejuni has emerged as a leading cause of bacterial enterocolitis. The serine protease
HtrA has been shown to be a pivotal, novel C. jejuni virulence factor involved in cell invasion and transmigration
across polarised epithelial cells in vitro. However, the functional relevance of the htrA gene for the interaction of C.
jejuni with the host immune system in the infant mouse infection model has not been investigated so far.
Results: Here we studied the role of C. jejuni htrA during infection of 3-weeks-old infant mice. Immediately after
weaning, conventional wild-type mice were perorally infected with the NCTC11168ΔhtrA mutant (ΔhtrA) or the
parental wild-type strain. Approximately one third of infected infant mice suffered from bloody diarrhea until day 7
post infection (p.i.), whereas colonic histopathological changes were rather moderate but comparable between the
two strains. Interestingly, parental, but not ΔhtrA mutant infected mice, displayed a multifold increase of apoptotic
cells in the colonic mucosa at day 7 p.i., which was paralleled by higher colonic levels of pro-inflammatory cytokines
such as TNF-α and IFN-γ and the matrix-degrading enzyme matrixmetalloproteinase-2 (MMP-2). Furthermore, higher
numbers of proliferating cells could be observed in the colon of ΔhtrA infected mice as compared to the parental
wild-type strain. Remarkably, as early as 7 days p.i. infant mice also exhibited inflammatory changes in extra-intestinal
compartments such as liver, kidneys and lungs, which were less distinct in kidneys and lungs following ΔhtrA versus
parental strain infection. However, live C. jejuni bacteria could not be found in these organs, suggesting the induction
of systemic effects during intestinal infection.
Conclusion: Upon C. jejuni ΔhtrA strain infection of infant mice, intestinal and extra-intestinal pro-inflammatory
immune responses were ameliorated in the infant mouse model system. Future studies will shed further light onto
the molecular mechanisms of host-pathogen interactions.
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Camplylobacter jejuni displays a major infectious agent of
foodborne bacterial enterocolitis of men with increasing
prevalence in developed as well as developing countries
[1,2]. Severity of campylobacteriosis varies from mild dis-
ease to acute symptoms such as abdominal cramps, fever,
myalgia, and watery to bloody diarrhea [3]. Patients suffer-
ing from acute disease display crypt abscesses, ulcerations
and colonic infiltration with pro-inflammatory immune
cell populations [4-6]. Whereas the vast majority of C.
jejuni infections is normally self-limiting in humans,
post-infectious sequelae such as Guillain-Barré syndrome,
Miller Fisher syndrome, Reiter’s syndrome and reactive
polyarthritis might arise in rare cases [3,7]. An important
prerequisite for C. jejuni causing disease is its ability to
adhere and invade intestinal epithelial cells [8]. A pleth-
ora of bacterial outer membrane proteins such as JlpA,
CadF, FlpA, PEB1 among others has been shown to be
involved in adhesion to epithelial cells [9-13], whereas
CadF can induce the activation of small Rho GTPases,
Rac1 and Cdc42, which exert invasive properties in vitro
[13-16] and in human ex vivo biopsies [17]. We and others
have recently shown that the C. jejuni serine protease and
chaperone HtrA (high temperature requirement A) dis-
plays a novel virulence factor [18-21]. Whereas HtrA fam-
ily members were considered in the past to strictly act
intracellularly in the bacteria, we recently discovered that
HtrA is actively secreted into the extracellular environ-
ment where it cleaves cell surface adhesion proteins and
tumor-suppressor E-cadherin [21-23]. In vitro infection
experiments with C. jejuni revealed that secreted HtrA is
capable of opening cell-to-cell-junctions in the epithelium
by cleaving-off the 90 kDa extracellular domain of E-
cadherin [21,22]. Furthermore, htrA gene deletion has
been shown to result in defective E-cadherin shedding
and compromised transmigration of C. jejuni across po-
larized epithelial cells in vitro [21].
The studies of molecular mechanisms of pathogen-
host-interactions causing C. jejuni induced disease have
been hampered by a lack of suitable in vivo models given
that the host-specific composition of the microbiota deter-
mines the physiological colonization resistance against C.
jejuni [24,25]. Whereas conventionally colonized adult
(>8-weeks-old) mice expel the pathogen within a few days
post infection, gnotobiotic wild-type mice and mice reco-
lonized with human microbiota were readily colonized by
C. jejuni [24]. However, classical clinical symptoms of hu-
man campylobacteriosis such as bloody diarrhea were
missing in these murine infection models [24]. In contrast
3-weeks-old infant mice are highly susceptible to C. jejuni
infection and develop self-limiting bloody diarrhea within
one week [25-30]. After resolving enterocolitis within
another 7–10 days, infant mice were asymptomatic
long-term C. jejuni carriers exhibiting distinct pro-inflammatory immune responses in intestinal as well
as extra-intestinal locations such as liver, lungs, and
kidneys characterized by influx of predominantly
T (and less distinctly B) lymphocytes after more than
3 months p.i. [25,31]. In the present study, we applied
the infant mouse model to investigate the functional
relevance of the htrA gene in C. jejuni infection
in vivo. Furthermore we studied potential extra-
intestinal inflammatory sequelae in the early course of
C. jejuni induced disease.
Results
Intestinal colonization and clinical symptoms in infant
mice following infection with wild-type and htrA mutant
C. jejuni
Immediately after weaning conventional 3-weeks-old in-
fant mice were perorally infected with approximately 109
colony forming units (CFU) of either the C. jejuni knock-
out mutant NCTC11168::htrA (ΔhtrA) or the parental
wild-type (WT) strain each harvested in the stationary
phase on two consecutive days (day 0 and 1). Control ana-
lyses demonstrated that equal amounts of C. jejuni protein
were infected per sample and the HtrA protein is not
expressed in the ΔhtrA mutant as expected (Figure 1A).
Seven days post infection (p.i.) less than half of parental
and ΔhtrA strain infected mice harboured the pathogen in
the large intestine (8.3% and 46.2%, respectively) with rela-
tively low pathogenic loads between 103 and 107 CFU per g
luminal content, whereas in the proximal and distal small
intestinal tract either C. jejuni strain was virtually un-
detectable (Figure 1B). In addition, approximately one
third of mice developed clinical symptoms of C. jejuni in-
duced acute enterocolitis until day 7 p.i., as indicated by
33.3% and 38.5% positive cases of bloody diarrhea in
parental and ΔhtrA strain infected mice, respectively
(Figure 2A). We next assessed gradual histopathological
changes in the mucosa and lamina propria of hematoxylin
and eosin (H&E) stained colonic paraffin sections. Seven
days following infection with either strain mice displayed
comparable histopathological scores and exhibited rather
mild to moderate colonic histopathological changes such
as single to mild scattered cell infiltrates within the co-
lonic mucosa and submucosa, mild epithelial hyperplasia
and starting loss of goblet cells (Figure 2B).
C. jejuni HtrA aggravates intestinal apoptosis and immune
responses
Given that apoptosis is a commonly used diagnostic
marker in the histopathological evaluation and grading
of intestinal disease [24] and a key feature of C. jejuni in-
duced ulcerative enterocolitis [25], we next quantitatively
assessed apoptotic cells applying in situ immunohisto-
chemical stainings of colonic paraffin sections. Seven
days following parental, but not ΔhtrA strain infection,
Figure 1 Influence of HtrA on C. jejuni colonization along the intestinal tract of infant mice. (A) Loading control (Coomassie blue staining)
of proteins from total cell lysates (top) and Western blot for the expression of HtrA in the two C. jejuni strains used in this infection study.
(B) Immediately after weaning, conventional infant wild-type mice were perorally infected with C. jejuni NCTC11168 (WT, closed circles) or the mutant
strain NCTC11168ΔhtrA (ΔhtrA, open circles). The pathogenic loads in distinct compartments of the intestinal tract were determined by quantification of
live C. jejuni in luminal samples taken from duodenum, ileum, and colon at day 7 following infection by cultural analysis (CFU, colony forming units).
Medians (black bars) are indicated and numbers of mice harbouring the respective C. jejuni strain out of the total numbers of analyzed animals are
given in parentheses. Data shown were pooled from three independent experiments.
Figure 2 Role of HtrA in clinical symptoms and colonic histopathology in C. jejuni infected infant mice. Immediately after weaning, infant
mice were perorally infected with C. jejuni NCTC11168 (WT, closed circles) or the mutant strain NCTC11168ΔhtrA (ΔhtrA, open circles). Uninfected
animals (Naïve; open diamonds) served as negative controls. Seven days following C. jejuni infection (A) occurrence of blood in fecal samples and
(B) histopathological changes in H&E stained colonic paraffin sections were assessed by applying standardized clinical and histophathological
scoring systems, respectively. Means (black bars) and numbers of analyzed animals (in parentheses) or absolute and relative (in %) numbers of
positive samples out of the total number are indicated. Data shown were pooled from three independent experiments.
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caspase3-positive apoptotic cell numbers as compared to
naïve controls (p < 0.05 vs. naïve; p < 0.0001 vs. ΔhtrA
strain; Figure 3A). Furthermore, ΔhtrA strain infected mice
exhibited more colonic Ki67-positive proliferating cells as
compared to parental strain infected and naïve controls
(p < 0.0005 and p < 0.001, respectively; Figure 3B) indica-
tive for upregulated regenerative epithelial function during
immunopathology. Given that recruitment of immune
cells is a hallmark of human campylobacteriosis [4,5] we
next quantitatively assessed T cell populations in the
large intestines of C. jejuni infected mice. Seven days
following ΔhtrA strain infection, infant mice displayed a
trend towards lower colonic CD3-positive T lymphocyte
numbers as compared to parental strain infected controlFigure 3 HtrA aggravates C. jejuni induced colonic apoptosis and infl
infected with C. jejuni NCTC11168 (WT, closed circles) or the mutant strain
diamonds) served as negative controls. The average numbers of apoptotic
Ki67, panel B), T lymphocytes (positive for CD3, panel C), and regulatory T
fields (HPF, 400× magnification) per animal were determined microscopica
addition, representative photomicrographs of colonic Casp3-positive apopt
proliferating (B, right panel) cells are shown (Naïve left, WT middle, ΔhtrA r
animals are given in parentheses. Means (black bars) and levels of significan
Data shown were pooled from three independent experiments.animals (not significant due to high SD in either group;
Figure 3C), whereas Foxp3-positive regulatory T cells
(Tregs) increased comparably in the colonic mucosa
and lamina propria of mice upon peroral infection with
either strain (Figure 3D).
C. jejuni HtrA is necessary for the induction of TNF-α,
IFN-γ and matrixmetalloproteinase-2
We next determined C. jejuni induced pro-inflammatory
cytokine responses in colonic ex vivo biopsies. Colonic
TNF-α protein and IFN-γ mRNA expression levels in-
creased almost two-fold 7 days following parental, but
not ΔhtrA infection (p < 0.01 and p < 0.05, respectively;
Figure 4) further underlining the role of HtrA in aggra-
vating C. jeuni mediated inflammation.ammation. Immediately after weaning, infant mice were perorally
NCTC11168ΔhtrA (ΔhtrA, open circles). Uninfected animals (Naïve; open
cells (positive for caspase-3, panel A), proliferating cells (positive for
cells (Treg, positive for Foxp3; panel D) from at least six high power
lly in immunohistochemically stained colonic sections at day 7 p.i. In
otic (indicated by black arrows; A, right panel) and Ki67-positive
ight photo; 400× magnification, scale bar 20 μm). Numbers of analyzed
ce (P-values) determined by the Mann–Whitney-U test are indicated.
Figure 4 HtrA impacts colonic pro-inflammatory cytokine expression during C. jejuni infection. Immediately after weaning, infant mice
were perorally infected with C. jejuni NCTC11168 (WT, closed circles) or the mutant strain NCTC11168ΔhtrA (ΔhtrA, open circles). Uninfected
animals (Naïve; open diamonds) served as negative controls. (A) TNF-α protein and (B) IFN-γ mRNA expression levels were determined in ex vivo
biopsies taken from colons at day 7 p.i. by ELISA and quantitative real time PCR technique, respectively. Numbers of analyzed animals are given in
parentheses. Means (black bars) and levels of significance (P-values) determined by the Mann–Whitney-U test are indicated. Data shown were
pooled from at least two independent experiments.
Figure 5 Colonic matrixmetalloproteinase-2 expression following C. jejuni infection of infant mice. Immediately after weaning, infant mice
were perorally infected with C. jejuni NCTC11168 (WT, closed circles) or the mutant strain NCTC11168ΔhtrA (ΔhtrA, open circles). Uninfected
animals (Naïve; open diamonds) served as negative controls. (A) MMP-2 and (B) TIMP-1 mRNA expression levels were determined in colonic
ex vivo biopsies taken at day 7 p.i. by quantitative real-time PCR. Numbers of analyzed animals are given in parentheses. Means (black bars) and
levels of significance (P-values) determined by the Mann–Whitney-U test are indicated. Data shown were pooled from three
independent experiments.
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metalloproteinase (MMP)-2 is upregulated during intestinal
immunopathology in mice and men [32-36], we next
assessed colonic expression levels of MMP-2 and its en-
dogenous inhibitor, the tissue inhibitor of matrixmetal-
loproteinase (TIMP)-1. Seven days following C. jejuni
infection, MMP-2 mRNA expression levels increased
multi-fold, but less distinctly in colons of ΔhtrA as com-
pared to parental strain infected mice (p < 0.05; Figure 5A).
Furthermore, colonic TIMP-1 mRNA expression was up-
regulated 7 days following parental but not ΔhtrA strain
infection (p < 0.01; Figure 5B). Taken together, absence of
the htrA gene is associated with less distinct C. jejuni in-
duced apoptosis and inflammation in the intestinal tract.
C. jejuni HtrA plays a crucial role in the induction of
extra-intestinal immune responses
We have recently shown that asymptomatic longterm
C. jejuni carrying mice displayed inflammatory im-
mune responses in extra-intestinal compartments such
as liver, kidneys and lungs [30]. We here investigated
extra-intestinal C. jejuni induced sequelae as early as
7 days p.i. To address this we quantified inflammatory
changes in H&E stained paraffin sections of liver, kid-
neys and lungs applying respective standardized histo-
pathological scores. Remarkably, 7 days following C.
jejuni infection with either strain mild to moderate
histopathological changes could be observed in extra-
intestinal organs that were exclusively lacking viable C.
jejuni (Figure 6). Whereas only subtle inflammatory in-
filtrates could be observed in livers of infected infant
mice irrespective of the C. jejuni strain (Figure 6A),
histopathological scores for kidneys and lungs were
lower in ΔhtrA mutant as compared to parental strainFigure 6 Role of HtrA in extra-intestinal histopathological sequelae fo
weaning, infant mice were perorally infected with C. jejuni NCTC11168 (WT
circles). Uninfected animals (Naïve; open diamonds) served as negative con
pathological sequelae were assessed in H&E stained paraffin sections taken
standardized histopathological scoring systems. Means (black bars), levels o
numbers of analyzed animals (in parentheses) are indicated. Data shown winfected animals at day 7 p.i. (Figure 6B, C), indicative
for less distinct inflammatory disease in the respective
extra-intestinal organs due to htrA deficiency of the C.
jejuni strain.
Taken together, upon ΔhtrA strain infection of infant
mice large intestinal pro-inflammatory immune responses
were ameliorated whereas compensatory regenerative/
proliferating properties of the epithelium were preserved.
Remarkably, C. jejuni induced inflammatory sequelae in
extra-intestinal organs such as liver, kidneys and lungs
could be observed as early as 7 days p.i., whereas extra-
intestinal responses were less pronounced in the latter
two compartments due to htrA deficiency.
Discussion
We have recently shown in vitro that the chaperone and
serine protease HtrA secreted by C. jejuni exerts a novel
pathogenicity factor that is involved in bacterial invasion
and transmigration across epithelial cells by cleaving E-
cadherin and opening cell-to-cell junctions [20-23]. In
the in vivo study presented here we investigated the im-
pact of the htrA gene in pathogen-host-interaction and
induction of immunopathology upon C. jejuni infection.
To address this, conventionally colonized infant mice were
infected either with the C. jejuni knockout mutant
NCTC11168ΔhtrA or its syngenic parental WT strain
at the age of 3 weeks immediatedly after weaning. Even
though only a subset of mice harboured the respective
strain in the intestinal tract, about one third of infected
mice suffered from bloody diarrhea. In a previous in-
fection study with another C. jejuni strain (B2), having
highly efficient colonizing properties, virtually all in-
fant mice harboured the pathogen at day 7 p.i., whereas
up to 90% of mice displayed bloody diarrhea [30].llowing C. jejuni infection of infant mice. Immediately after
, closed circles) or the mutant strain NCTC11168ΔhtrA (ΔhtrA, open
trols. Seven days following C. jejuni infection extra-intestinal immuno-
from (A) liver, (B) kidneys, and (C) lungs by applying respective
f significance (P-values) determined by the Mann–Whitney-U test and
ere pooled from three independent experiments.
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NCTC11168, but not ΔhtrA mutant infected infant mice
exhibited multi-fold increased numbers of colonic apop-
totic cells at day 7 p.i. as compared to naïve controls.
Conversely, the number of proliferating cells was signifi-
cantly increased in ΔhtrA but not parental strain in-
fected mice indicative for up-regulated regenerative
properties of intestinal epithelial cells thereby counter-
acting C. jejuni induced tissue damage. Less pro-
nounced intestinal immunopathology due to the
absence of HtrA was further underlined by lower ex-
pression levels of colonic pro-inflammatory cytokines
such as TNF-α and IFN-γ, which have been shown to be
key cytokines mediating C. jejuni induced immunopa-
thology in murine infection models with different clin-
ical severity [24,25]. Interestingly, less distinct intestinal
immunopathology was accompanied by lower colonic
expression levels of the matrix-degrading enzyme
MMP-2 and its endogenous inhibitor TIMP-1 seven
days following ΔhtrA as compared to the parental strain
infection. These MMP expression data are in good
agreement with previous studies demonstrating that
MMP-2 is up-regulated in acute and chronic small as
well as large intestinal inflammation in mice and men
[32,33,35-38]. For the first time we have now presented
evidence that MMP-2 might also play an important role
in mediating C. jejuni-induced disease, which is cur-
rently further unravelled in ongoing studies.
Surprisingly, rather mild to moderate histopathological
sequelae of C. jejuni infection could be detected as early
as one week in extra-intestinal organs such as liver, kid-
neys and lungs. All organ samples were free of viable C.
jejuni as shown by negative cultures. In our previous
study, C. jejuni B2 strain infected infant mice exhibited
histopathological changes in the respective organs more
than 100 days p.i. [30] with inflammatory foci consisting
mainly of accumulated CD3-positive T cells [31]. Strik-
ingly, in the present study, extra-intestinal histopatho-
logical changes in kidneys and lungs were less distinct
one week following ΔhtrA as compared to parental
strain infection. Hence, absence of the HtrA protein is
not only associated with less pronounced intestinal but
also extra-intestinal inflammation.
In humans, only very few cases of pathogen-associated
disease manifestations affecting liver, lungs, heart or spleen
have been reported in severely immuno-compromized
patients with C. jejuni bacteremia [39-41]. Fauchere and
coworkers showed in isolator-raised germfree mice that
C. jejuni was cleared from extra-intestinal compartments
such as liver and spleen and the circulation within 24 hours
following infection most likely due to non-specific bacteri-
cidal factors such as phagocytes and complement [42].
Histopathological changes within extra-intestinal organs,
however, were not investigated [42]. In the context withour previous observation that CD3-positive cells accumu-
late at extra-intestinal locations, it is tempting to speculate
that potentially pro-inflammatory immune cell popula-
tions might be attracted to the extra-intestinal compart-
ments very early following infection before the subsequent
clearing of the pathogen. These immune cells might then
further reside in the respective organs and explain the
sterile inflammatory responses in extra-intestinal tissue
sites observed 7 days p.i. as well as in asymptomatic long-
term C. jejuni carriers more than 100 days p.i. [30,31].Conclusions
Our in vivo study using the infant mouse infection model
provides clear evidence for the importance of HtrA as a
new virulence factor mediating C. jejuni induced intestinal
as well as extra-intestinal immune responses. Thus, we de-
scribe here the first known C. jejuni mutant with very high
motility [21], but having very low potential to trigger in-
testinal inflammation and bloody diarrhea as compared to
WT bacteria. Future studies will further elucidate the
underlying molecular mechanisms of C. jejuni-host-
interactions.Materials and methods
Ethics statement
All animal experiments were conducted according to the
European Guidelines for animal welfare (2010/63/EU)
with approval of the commission for animal experiments
headed by the “Landesamt für Gesundheit und Soziales”
(LaGeSo, Berlin, Germany; registration numbers G0123/
12). Animal welfare was monitored twice daily by assess-
ment of clinical conditions.Mice and C. jejuni infection
All mice were bred and maintained under specific
pathogen-free (SPF) conditions in the facilities of the
“Forschungseinrichtung für Experimentelle Medizin” (FEM,
Charité - Universitätsmedizin, Berlin, Germany). Immedi-
ately after weaning, female 3-weeks-old C57BL/6 mice
were infected orally with approximately 109 viable CFU of
the C. jejuni parental WT strain NCTC11168 or the iso-
genic mutant strain NCTC11168ΔhtrA lacking the htrA
gene [21,22] by gavage in a total volume of 0.3 mL PBS on
two consecutive days (day 0 and day 1).Clinical signs of C. jejuni infection, bloody feces
To assess clinical signs of C. jejuni induced infection,
the occurrence of blood in fecal samples was determined
applying a standardized score (0 points: no blood; 2
points: microscopic detection of blood by the Guajac
method using Haemoccult, Beckman Coulter/PCD,
Krefeld, Germany; 4 points: overt blood visible) [25,43].
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Mice were sacrificed by isofluran treatment (Abbott,
Germany). Tissue samples from liver, kidneys, lungs, and
intestinal tract (duodenum, ileum, colon) were removed
under sterile conditions. Intestinal samples from each
mouse were collected in parallel for histopathological,
immunohistochemical, microbiological, and immuno-
logical analyses. Immunohistopathological changes were
determined in samples derived from colon, liver, kidneys
and lungs that were immediately fixed in 5% formalin
and embedded in paraffin. Sections (5 μm) were stained
with H&E, examined by light microscopy (magnification
100× and 400×) and histopathological changes quantita-
tively assessed by two independent double-blinded in-
vestigators applying respective histopathological scoring
systems. In brief:
Colonic histopathology (max. 4 points; according to
[44]): 0: no inflammation; 1: single isolated cell infiltrates
within the mucosa, no epithelial hyperplasia; 2: mild
scattered to diffuse cell infiltrates within the mucosa and
submucosa; mild epithelial hyperplasia; starting loss of
goblet cells; 3: cell infiltrates within mucosa, submucosa,
and sometimes transmural; epithelial hyperplasia; loss of
goblet cells; 4: cell infiltrates within mucosa, submucosa,
and transmural; severe inflammation; loss of goblet cells,
loss of crypts; ulcerations; severe epithelial hyperplasia.
Hepatic histopathology (max. 9 points; modified
Ishak score [45]): Lobular inflammation: 0: normal; 1:
minimal inflammation (few inflammatory infiltrates);
2: mild inflammation (increased inflammatory cells, but
less pyknotic necrosis); 3: moderate inflammation
(marked increase in inflammatory cells and lots of
pyknotic necroses); 4: severe inflammation (necrosis); 5:
severe inflammation (plus bridging necroses).
Portal inflammation: 0: normal; 1: mild inflammation (<1/
3 of portal tracts); 2: moderate inflammation (ca. 1/2 of
portal tracts); 3: severe inflammation (>2/3 of portal
tracts); 4: severe inflammation (plus portal inflammation
disperse into parenchyma).
Renal histopathology (max. 4 points; according to [46]):
0: normal glomerulus; 1: focal and mild hypercellularity
(normal = 3 per segment); 2: multifocal and moderate
hypercellularity with capillary dilatation and mild
hyalinosis; 3: diffuse hypercellularity (>50% of the tuft)
and capillary aneurysm; 4: extensive sclerosis/crescents,
tuft obliteration, collapse.
Pulmonal histopathology (max. 4 points, modified
according to [47]):
0: no inflammation; 1: perivascular cuff of inflammatory
cells; 2: mild inflammation, extending throughout <25%
of the lung; 3: moderate inflammation covering 25-50%
of the lung; 4: severe inflammation involving >50% of
the lung.Immunohistochemistry
In situ immunohistochemical analyses of 5 μm thin co-
lonic paraffin sections were performed as described pre-
viously [24,25,30,31,48]. Primary antibodies against
cleaved caspase-3 (Asp175, Cell Signaling, USA, 1:200),
Ki67 (TEC3, Dako, Denmark, 1:100), CD3 (M-20, Santa
Cruz, 1:1000), and Foxp3 (FJK-16 s, eBioscience, 1:100)
were used. For each animal the average number of posi-
tively stained cells within at least six high power fields
(HPF, 0.287 mm2; 400× magnification) was determined
microscopically by two independent double-blinded
investigators.
Quantitative analysis of C. jejuni
At time of necropsy (day 7 p.i.) live C. jejuni were de-
tected in luminal samples derived from the duodenum,
ileum or colon dissolved in sterile PBS by culture as de-
scribed earlier [24,31]. In brief, serial dilutions of fecal
samples were streaked out on karmali agar (Oxoid,
Wesel, Germany) and incubated in a microaerobic atmos-
phere at 37°C for at least 48 hours. The respective weights
of luminal fecal samples were determined by the difference
of the sample weights before and after asservation.
Cytokine detection in colonic ex vivo biopsies
Colonic biopsies were cut longitudinally and washed in
PBS. Strips of approximately 1 cm2 colon were placed in
24-flat-bottom well culture plates (Nunc, Wiesbaden,
Germany) containing 500 μL serum-free RPMI 1640
medium supplemented with penicillin (100 U/ mL) and
streptomycin (100 μg/ mL; PAA Laboratories). After
18 h at 37°C supernatants were tested for TNF-α by
ELISA (BD Biosciences).
Real-time PCR analysis
RNA was isolated from colonic tissues using the RNeasy
Mini Kit (Qiagen). mRNA was reversed transcribed and
analysed in triplicate assays by TaqMan PCR using a se-
quence detection system (ABI Prism 7700; Applied Bio-
systems) as described previously [35,49]. For detection
of murine IFN-γ, MMP-2 and TIMP-1 assays including
double-fluorescent probes in combination with assays
for the mouse housekeeping gene hypoxanthine phos-
phoribosyltransferase (HPRT) were purchased from
Applied Biosystems). Expression levels were calculated
relative to the HPRT expression.
Antibodies and Western blotting
C. jejuni cell pellets were lysed and proteins were sepa-
rated by SDS-PAGE [50,51]. Coomassie blue staining
was done as described [52]. The polyclonal rabbit α-
HtrA antibody was raised against a conserved peptide
corresponding to amino acid (aa) residues 288–301: C-
QGDTKKAYKNQEGA. The peptide was conjugated to
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two rabbits each were immunized by Biogenes GmbH
(Berlin, Germany) using standard protocols [53]. The
resulting antiserum was affinity-purified and the specificity
against the proteins in C. jejuni was confirmed by Western
blotting [54,55]. Horseradish peroxidase-conjugated
anti-rabbit polyvalent sheep immunoglobulin was used
as secondary antibody (DAKO Denmark A/S, DK-2600
Glostrup, Denmark). Blots were developed with ECL
Plus Western blot reagents (GE Healthcare, UK limited
Amersham Place, UK) as described [56,57].
Statistical analysis
Mean values, medians, and levels of significance were de-
termined using Mann–Whitney-U test. Two-sided pro-
bability (P) values ≤ 0.05 were considered significant. All
experiments were repeated at least twice.
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